Interestingly, peripheral lipid hydroperoxides explained more than half of the variance in white matter alterations in BD patients, using diffusion tensor imaging measures [153]
The distinction between FDA-approved GLP-1 medications further complicates Medicaid coverage: some state programs cover semaglutide (Ozempic/Wegovy) and tirzepatide (Zepbound/Mounjaro) while excluding newer compounds, or may cover injectable forms but not oral versions
Patients with certain genetic profiles may feel fuller longer if tirzepatide peaks during their highest-stress eating windows
Numerous studies have shown that effective reduction in body weight, as compared to placebo
Karalyn Bentley, MD, FACS Bariatric Surgery +4 more BRG Select Provider Tuan Tran, MD Bariatric Surgery +3 more BRG Select Provider Medical Weight Loss For patients who are not candidates for surgery, or who prefer a non-surgical approach, BRG offers medical weight loss programs that use advanced therapies like GLP-1 medications
If unexplained weight gain is your primary concern, a medical weight loss evaluation can identify whether hormones are the driver